NPPB and heart failure: Current study findings align with previous publications showing that adding vericiguat to guideline standard heart failure treatment for patients with heart failure with reduced ejection fraction decreases rehospitalisation rates and improves left ventricular ejection fraction and decreases levels of NT-proBNP.